English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/17942
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy–6H–dibenzopyran–6– one derivatives by the colonic microflora of healthy humans

AutorCerdá, Begoña; Espín de Gea, Juan Carlos ; Parra, S.; Martínez, P.; Tomás Barberán, Francisco
Palabras claveBioavailability
Antioxidant
Metabolism
Hydroxy–6H–dibenzo [b,d] pyran–6–one
Ellagitannin
Polyphenol
Punicalagin
Microbial metabolites
Pomegranate juice
Punica granatum
Fecha de publicación6-ene-2004
EditorSpringer
CitaciónEuropean Journal of Nutrition 43(4): 205-220 (2004)
Resumen[Background]: The antiatherogenic activity of pomegranate juice has been attributed to its antioxidant polyphenols. The most potent in vitro antioxidant polyphenol from this juice is the ellagitannin punicalagin. However, the bioavailability of ellagitannins, including punicalagin, has not been previously described in humans.
[Aim of the study]: The present work aims to evaluate, in healthy humans, the bioavailability and metabolism of pomegranate juice ellagitannins, to assess their effect on several blood parameters (including cardiovascular risk disease markers) and to compare the antioxidant activity of punicalagin with that of the in vivo generated metabolites.
[Design]: Six healthy subjects (four men and two women) consumed 1 L of pomegranate juice daily (5.58 g/L polyphenols, including 4.37 g/L punicalagin isomers) for 5 days. The polyphenols and the in vivo generated metabolites were measured by HPLC–DAD–MS–MS. Fourteen haematological and twenty serobiochemical parameters including LDL, HDL and VLDL as well as cholesterol and triglycerides in each lipoprotein were evaluated. In vitro antioxidant activity of plasma (ABTS and FRAP assays) and urine (ABTS and DPPH) were determined.
[Results]: Neither punicalagin nor ellagic acid present in the juice were detected in both plasma and urine. Three microbial ellagitannin-derived metabolites were detected: 3,8–dihydroxy–6H–dibenzo[b,d] pyran–6–one glucuronide, an unidentified aglycone (tentatively, trihydroxy–6H–dibenzo[b,d]pyran–6–one) and hydroxy–6–Hdibenzo[ b,d]pyran–6–one glucuronide. These metabolites could reach up to 18.6 µM in plasma, although a large inter–individual variability was observed. In urine, the same metabolites and their corresponding aglycones became evident after 1 day of juice consumption. Total urine excretion of metabolites ranged from 0.7 to 52.7% regarding the ingested punicalagin. No relevant effect was observed on any blood parameter. The metabolites did not show significant antioxidant activity compared to punicalagin from pomegranate juice.
[Conclusions]: The potential systemic biological effects of pomegranate juice ingestion should be attributed to the colonic microflora metabolites rather than to the polyphenols present in the juice.
Descripción16 pages, 3 tables, 7 figures.-- Online version published Jan 2004.
Versión del editorhttp://dx.doi.org/10.1007/s00394-004-0461-7
URIhttp://hdl.handle.net/10261/17942
DOI10.1007/s00394-004-0461-7
ISSN1436-6207 (Print)
1436-6215 (Online)
Aparece en las colecciones: (CEBAS) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.